Article metrics

Download PDFPDF
A phase II trial of intravenous etoposide (VP-16-213) in epithelial ovarian cancer resistant to cisplatin or carboplatin: clinical and serological evidence of activity

 

Online download statistics by month:

Online download statistics by month: January 2019 to November 2021

AbstractFullPdf
Jan 2019600
Feb 20191801
Mar 2019600
Apr 2019400
May 2019800
Jun 20191201
Jul 2019802
Aug 2019902
Sep 2019400
Oct 2019600
Nov 2019400
Dec 2019600
Jan 20202800
Feb 2020600
Apr 2020200
May 20201800
Jun 2020600
Jul 20201200
Aug 20201400
Sep 20204200
Oct 20201101
Nov 2020200
Dec 2020600
Jan 20211300
Feb 2021200
Mar 20211800
May 2021400
Oct 20211200
Nov 20211600
Total30307